Physitrack plc

09/14/2026 | Press release | Distributed by Public on 09/14/2026 00:34

Physitrack PLC — Transactions under Share Buy-back Programme

English Published: 2026-09-14 08:30:00 CEST Physitrack PLC - Other information disclosed according to the rules of the Exchange

Physitrack PLC - Transactions under Share Buy-back Programme

Physitrack PLC ("Physitrack" or the "Company") announces that, pursuant to the share buy-back programme announced on 21 July 2026, the Company has purchased its own ordinary shares on Nasdaq First North Growth Market Stockholm during the week of 7 September 2026 to 11 September 2026, as set out below.

Summary of transactions

Period Total shares repurchased during the week Volume-weighted average price paid (SEK) Total consideration paid (SEK) Total shares held by the Company (treasury) following these transactions Total outstanding shares in the Company Treasury holding as % of issued share capital
7 September 2026 - 11 September 2026 6,442 SEK 8.4780 SEK 54,615.10 33,033 16,260,766 0.2031%


Individual transactions

Date Quantity Average price (SEK)
2026-09-07 1,750 8.6743
2026-09-08 1,500 8.4733
2026-09-09 692 8.3600
2026-09-10 1,500 8.4000
2026-09-11 1,000 8.3400


The share buy-back programme is conducted within the safe harbour of Article 5 of the Market Abuse Regulation (EU) No 596/2014 ("MAR") and Commission Delegated Regulation (EU) 2016/1052, for the purpose of meeting the Company's obligations under its employee share plans. The programme is executed by Pareto Securities on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details

1. Issuer Physitrack PLC, LEI 213800PC4QYNWHPCP774
2. Instrument/ISIN Ordinary shares / GB00BYX22590
3. Trading venue Nasdaq First North Growth Market Stockholm (PTRK)
4. Currency SEK
5. Purpose of buy-back To meet the Company's obligations under its employee share plans (a permitted purpose under Article 5(2) of MAR)
6. Executing broker Pareto Securities (non-discretionary mandate)


This information is disclosed pursuant to Article 5 of MAR and Commission Delegated Regulation (EU) 2016/1052.

About Physitrack

Physitrack plc (Nasdaq First North: PTRK), d/b/a Physitrack Group, is a global digital health and wellness SaaS delivering personalized, scalable remote care through its Physitrack and Champion Health platforms.
Physitrack enables healthcare providers to deliver and manage app-guided physical and occupational rehabilitation with measurable patient outcomes and built-in billing and reimbursement support, while Champion Health provides businesses with mental, physical, and financial wellbeing solutions to support workforce health and productivity.

Physitrack Group's solutions seamlessly integrate with existing systems, including EMR/EHR/PMS connectivity, and are trusted by more than 80,000 providers and organizations across 180+ countries. For more information, visit www.physitrackgroup.com and follow us on LinkedIn and X.

Enquiries regarding this announcement should be addressed to:

Corporate Contact:
Henrik Molin, CEO and co-founder, Physitrack
[email protected]
[email protected]

Investor and Media Contact:
Investor Relations
[email protected]
Tel +1 475 477 9401

Physitrack PLC - Transactions under Share Buy-back Programme.pdf https://attachment.news.eu.nasdaq.com/afcf99aeb88fbfdf764a842bb24d88d54
Company News Subscribe European Market Activity Nasdaq Europe
© 2026, Nasdaq, Inc. All Rights Reserved.
Physitrack plc published this content on September 14, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 14, 2026 at 06:34 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]